Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menggang Yu

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Molecular Cancer|April 2, 2010
Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinomaJian-Min Wu, Yan Xu, Nicholas J Skill, et al.
Cancer Journal (Sudbury, Mass.)|June 8, 2015
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic ReviewAndrew P Stein, Sandeep Saha, Jennifer L Kraninger, et al.
Leukemia Research|May 11, 2011
Genetic disruption of the scaffolding protein, Kinase Suppressor of Ras 1 (KSR1), differentially regulates GM-CSF-stimulated hyperproliferation in hematopoietic progenitors expressing activating PTPN11 mutants D61Y and E76KZhenyun Yang, Mia Chen, Sarah A Sitarski, et al.
Cancer Treatment Reviews|June 2, 2012
Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysisShanthi Sivendran, Ziyue Liu, Louis J Portas, et al.
CA: a Cancer Journal for Clinicians|January 29, 2013
Risk factors, pathophysiology, and treatment of hot flashes in cancerWilliam I Fisher, Aimee K Johnson, Gary R Elkins, et al.
Breast Cancer Research and Treatment|June 5, 2025
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancersSneha Phadke, Kathy D Miller, Ami Shah, et al.
Cancer Letters|March 24, 2009
NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapyJian-Min Wu, Hongmiao Sheng, Romil Saxena, et al.
The Journal of Investigative Dermatology|November 6, 2018
Chemoprotective Effects of Dietary Grape Powder on UVB Radiation-Mediated Skin Carcinogenesis in SKH-1 Hairless MiceChandra K Singh, Charlotte A Mintie, Mary A Ndiaye, et al.
Plos One|June 2, 2015
Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast TumorsDavid Shlensky, Jennifer A Mirrielees, Zibo Zhao, et al.
Scientific Reports|April 25, 2026
Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinomaTejaswi Worlikar, Man Zhang, Menggang Yu, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Molecular Cancer|April 2, 2010
Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinomaJian-Min Wu, Yan Xu, Nicholas J Skill, et al.
Cancer Journal (Sudbury, Mass.)|June 8, 2015
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic ReviewAndrew P Stein, Sandeep Saha, Jennifer L Kraninger, et al.
Leukemia Research|May 11, 2011
Genetic disruption of the scaffolding protein, Kinase Suppressor of Ras 1 (KSR1), differentially regulates GM-CSF-stimulated hyperproliferation in hematopoietic progenitors expressing activating PTPN11 mutants D61Y and E76KZhenyun Yang, Mia Chen, Sarah A Sitarski, et al.
Cancer Treatment Reviews|June 2, 2012
Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysisShanthi Sivendran, Ziyue Liu, Louis J Portas, et al.
CA: a Cancer Journal for Clinicians|January 29, 2013
Risk factors, pathophysiology, and treatment of hot flashes in cancerWilliam I Fisher, Aimee K Johnson, Gary R Elkins, et al.
Breast Cancer Research and Treatment|June 5, 2025
Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancersSneha Phadke, Kathy D Miller, Ami Shah, et al.
Cancer Letters|March 24, 2009
NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapyJian-Min Wu, Hongmiao Sheng, Romil Saxena, et al.
The Journal of Investigative Dermatology|November 6, 2018
Chemoprotective Effects of Dietary Grape Powder on UVB Radiation-Mediated Skin Carcinogenesis in SKH-1 Hairless MiceChandra K Singh, Charlotte A Mintie, Mary A Ndiaye, et al.
Plos One|June 2, 2015
Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast TumorsDavid Shlensky, Jennifer A Mirrielees, Zibo Zhao, et al.
Scientific Reports|April 25, 2026
Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinomaTejaswi Worlikar, Man Zhang, Menggang Yu, et al.
Pageof 18